McKesson (NYSE:MCK) Updates FY25 Earnings Guidance

McKesson (NYSE:MCK - Get Free Report) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $31.25-$32.05 for the period, compared to the consensus estimate of $31.09. The company issued revenue guidance of $355.35-$361.53 billion, compared to the consensus revenue estimate of $341.05 billion.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Leerink Partnrs reaffirmed an outperform rating on shares of McKesson in a report on Monday, February 26th. StockNews.com raised McKesson from a buy rating to a strong-buy rating in a research note on Saturday. UBS Group boosted their price objective on McKesson from $575.00 to $620.00 and gave the stock a buy rating in a research note on Wednesday, March 6th. SVB Leerink assumed coverage on McKesson in a research note on Monday, February 26th. They set an outperform rating and a $600.00 target price for the company. Finally, Mizuho lifted their target price on McKesson from $450.00 to $505.00 and gave the stock a neutral rating in a report on Friday, February 9th. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $536.71.

McKesson Stock Up 2.1 %

Shares of McKesson stock traded up $11.12 during trading on Tuesday, hitting $544.53. The stock had a trading volume of 983,843 shares, compared to its average volume of 705,665. McKesson has a 1 year low of $364.08 and a 1 year high of $546.63. The stock has a 50 day simple moving average of $531.17 and a 200 day simple moving average of $493.81. The company has a market capitalization of $71.56 billion, a PE ratio of 24.67, a P/E/G ratio of 1.41 and a beta of 0.45.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, topping the consensus estimate of $7.05 by $0.69. The firm had revenue of $80.90 billion for the quarter, compared to analysts' expectations of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The company's quarterly revenue was up 14.8% compared to the same quarter last year. During the same period in the previous year, the company posted $6.90 EPS. As a group, equities analysts expect that McKesson will post 27.59 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be given a dividend of $0.62 per share. The ex-dividend date is Friday, May 31st. This represents a $2.48 dividend on an annualized basis and a yield of 0.46%. McKesson's payout ratio is presently 11.24%.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 186 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now owns 1,511 shares in the company, valued at approximately $749,456. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other McKesson news, EVP Leann B. Smith sold 186 shares of the business's stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the firm's stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now directly owns 43,445 shares of the company's stock, valued at $22,789,074.75. The disclosure for this sale can be found here. 0.21% of the stock is owned by corporate insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.